Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Pachamuthu Kandasamy und 24 weiteren Autor:innen. Beteiligte Einrichtung: Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts 02142, United States. Hauptthemen laut MEDLINE: Asialoglycoprotein Receptor, Galactosamine, RNA, Small Interfering, RNA-Induced Silencing Complex. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Conjugation of synthetic triantennary N-acetyl-d-galactosamine (GalNAc) to small interfering RNA (siRNA) mediates binding to the asialoglycoprotein receptor (ASGPR) on the surface of hepatocytes, facilitating liver-specific uptake and siRNA-mediated gene silencing. The natural β-glycosidic bond of the GalNAc ligand is rapidly cleaved by glycosidases in vivo. Novel GalNAc ligands with S-, and C-glycosides with both α- and β-anomeric linkages, N-glycosides with β-anomeric linkage, and the O-glycoside with α-anomeric linkage were synthesized and conjugated to siRNA either on-column during siRNA synthesis or through a high-throughput, post-synthetic method. Unlike natural GalNAc, modified ligands were resistant to glycosidase activity. The siRNAs conjugated to newly designed ligands had similar affinities for ASGPR and similar silencing activity in mice as the parent GalNAc-siRNA conjugate. These data suggest that other factors, such as protein-nucleic acid interactions and loading of the antisense strand into the RNA-induced silencing complex (RISC), are more critical to the duration of action than the stereochemistry and stability of the anomeric linkage between the GalNAc moiety of the ligand conjugated to the sense strand of the siRNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts 02142, United States.
- Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232, United States.
ORCID-Profile: Shohei Mori, Ju Liu, Kallanthottathil G Rajeev, Martin Egli, Muthiah Manoharan
Zitieren
APA
Kandasamy, P., Mori, S., Matsuda, S., Erande, N., Datta, D., Willoughby, J. L. S., Taneja, N., O'Shea, J., Bisbe, A., Manoharan, R. M., Yucius, K., Nguyen, T., Indrakanti, R., Gupta, S., Gilbert, J. A., Racie, T., Chan, A., Liu, J., Hutabarat, R., …, & Manoharan, M. (2023). Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01337
Vancouver
Kandasamy P, Mori S, Matsuda S, Erande N, Datta D, Willoughby JLS, et al. Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01337
BibTeX
@article{Kandasamy2023,
author = {Kandasamy, Pachamuthu and Mori, Shohei and Matsuda, Shigeo and Erande, Namrata and Datta, Dhrubajyoti and Willoughby, Jennifer L S and Taneja, Nate and O'Shea, Jonathan and Bisbe, Anna and Manoharan, Rajar M and Yucius, Kristina and Nguyen, Tuyen and Indrakanti, Ramesh and Gupta, Swati and Gilbert, Jason A and Racie, Tim and Chan, Amy and Liu, Ju and Hutabarat, Renta and Nair, Jayaprakash K and Charisse, Klaus and Maier, Martin A and Rajeev, Kallanthottathil G and Egli, Martin and Manoharan, Muthiah},
title = {Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01337}
}
EUVIMED